# The Role of Negr1 In Modulating Neuroplasticity in Major Depression (RONIN)

> **NCT06131268** · PHASE4 · UNKNOWN · sponsor: **Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico** · enrollment: 30 (estimated)

## Conditions studied

- Major Depressive Disorder
- Bipolar Affective Disorder, Currently Depressed, Moderate

## Interventions

- **DRUG:** Venlafaxine

## Key facts

- **NCT ID:** NCT06131268
- **Lead sponsor:** Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-01
- **Primary completion:** 2024-03-01
- **Final completion:** 2024-04-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06131268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06131268, "The Role of Negr1 In Modulating Neuroplasticity in Major Depression (RONIN)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06131268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*